ClinicalTrials.Veeva

Menu

Relationship Between Gestational Diabetes Mellitus and Inflammatory Adipocytokins in Obese Mothers and Their Newborn at Delivery (ADIPOGEST)

C

Centre Hospitalier Universitaire de la Réunion

Status

Unknown

Conditions

Diabetes, Gestational

Study type

Observational

Funder types

Other

Identifiers

NCT02905487
2012/CHU/ADIPOGEST

Details and patient eligibility

About

ADIPOGEST study aims at comparing circulating levels of inflammatory adipocytokins and C-reactive protein in obese women and their newborn at delivery whether exposed or not to Gestational Diabetes Mellitus (GDM)

Full description

ADIPOGEST is a cross sectional study in which mothers are divided into 2 groups : exposed and unexposed to GDM, matched on pregestational BMI, date of delivery and child gender.

Mothers are recruited in the maternity ward of the University Hospital in South of Reunion Island.

It is planned a conveniance sample of 20 mother-child pairs per group.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women
  • Obese women (BMI : 30 kg/m² or more)
  • Aged over 18 years
  • With single pregnancy
  • With alive newborn at 37 weeks of amenorrhea or more
  • With informed consent

Exclusion criteria

  • Smoker
  • Treatments by corticoïds or thyroid hormons
  • Overt diabetes
  • Complicated pregnancy
  • Premature delivery threat

Trial design

40 participants in 2 patient groups

GDM
Description:
Mother-child pairs from mothers with GDM diagnosis (ADA, 2012)
No GDM
Description:
Mother-child pairs from mothers without GDM diagnosis (ADA, 2012)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems